2'-Deoxy-4'-C-ethynyl-2-fluoroadenosine
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
865363-93-5C#C[C@]1(CO)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1OIKKXOSBHLYMWAE-QRPMWFLTSA-NIslatravir is under investigation in clinical trial NCT04233216 (Doravirine/islatravir (DOR/ISL) in Heavily Treatment-experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)).
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P260, P264, P270, P301+P316, P308+P316, P319, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 36 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.
Compounds that inhibit cell production of DNA or RNA.
Agents used to treat RETROVIRIDAE INFECTIONS.
使用4'-ethynyl-2-fluoro-2'-deoxyadenosine (Islatravir) is a heterocyclic organic compound and can be used as pharmaceutical intermediates.
865363-93-5DTXSID601046407CHEMBL517231